Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent

NCT01939249 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

585

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: Abbott Laboratories Xience
DEVICE: Biotronik Orsiro

Sponsor

Biotronik AG